| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62f941494409aea84f621977c5f0ab81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cee5f6b519deb93e9abc825a891a5e5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate |
1991-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e19cc848fab057a435c14f097ace6429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88a2d0661b2582882c143b554c742939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0126c28e45b9a603b4d1503e37b4881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e005b18426ba9de45d98a7cedc44c3a4 |
| publicationDate |
1992-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2098609-A1 |
| titleOfInvention |
Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| abstract |
The present invention provides uses for Calpain inhibitor compounds and also provides pharmaceutical compositions containing Calpain inhibitor compounds. One use of these compounds is in the treatment of a neurodegenerative pathology in a human patient. The invention also provides additional uses and pharmaceutical compositions containing Calpain inhibitor compounds, such as Peptide Ketoamides, Peptide Ketoacids and Peptide Ketoesters. |
| priorityDate |
1990-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |